Magnesium Supplement Side Effects: What the Evidence Says About Safety and Risks

Magnesium supplements have become one of the most popular products in the wellness aisle, and not without reason. Nearly half of Americans don’t get enough magnesium from food alone, according to national survey data, and the mineral drives more than 300 enzymatic reactions. But the question people tend to skip — the one that actually matters — is safety. At what dose, in what form, and for whom.

The evidence on magnesium’s safety is largely reassuring, but it’s more layered than most consumers realise. Side effects exist. They vary significantly by formulation. And a handful of recent studies have complicated the consensus that more magnesium is always better.

What actually happens when you take too much

The most common adverse effects are gastrointestinal: diarrhea, abdominal cramping, and nausea. These aren’t idiosyncratic toxicities. They’re a direct consequence of how magnesium salts behave in the gut. Unabsorbed magnesium draws water into the colon through an osmotic effect, accelerating transit time and, at sufficient doses, producing the laxative effect magnesium is prescribed for in clinical settings.

The severity depends heavily on the form. Magnesium oxide, the cheapest and most widely available, has an absorption rate of roughly 4 to 5 percent in healthy adults, meaning the overwhelming majority stays in the gut. Magnesium citrate achieves absorption rates in the range of 24 to 30 percent, but its citrate component itself acts as an osmotic laxative. Magnesium glycinate and bisglycinate, chelated to the amino acid glycine, are generally better tolerated, with absorption comparable to citrate and a lower likelihood of GI distress. The data on tolerability differences, however, is more anecdotal than systematic.

The NIH set the Tolerable Upper Intake Level for supplemental magnesium at 350 milligrams per day for adults. That number is a ceiling, not a target, and it applies only to magnesium from supplements, not from food. Dietary magnesium doesn’t produce the same osmotic effects because it is bound within the food matrix and absorbed more gradually.

The quiet debate over the upper limit

That 350 mg ceiling is now under reconsideration. In April 2025, the Council for Responsible Nutrition — the supplements industry’s primary trade association — released an updated risk assessment proposing a safe upper intake level of 500 mg per day for healthy adults. The re-evaluation, led by CRN Senior Vice President Andrea Wong, drew on 68 clinical trials published after 2014 that reported no serious adverse events at doses up to 500 mg.

“This updated UL reflects a growing body of evidence that magnesium is well tolerated — even at higher levels than previously recognized,” Wong said.

The gap between 350 and 500 mg is not trivial. It’s the difference between a standard two-capsule serving of many glycinate products (typically 200 to 400 mg of elemental magnesium) and a dose that would push past the NIH’s safety threshold. Clinicians navigate this gap daily, particularly for patients using magnesium for migraine prophylaxis, where doses of 400 to 600 mg appear in the clinical literature.

Still, the CRN’s assessment comes from an industry body, and no regulatory agency has adopted the 500 mg figure. For now, the NIH’s 350 mg UL remains the conservative reference point — and the one most physicians recognize.

When magnesium becomes dangerous

True hypermagnesemia — a serum magnesium level above 0.7 to 1.0 mmol/L — is rare in people with healthy kidneys because the kidneys are exceptionally efficient at excreting excess magnesium. In patients with chronic kidney disease (CKD), particularly those with an eGFR below 30 mL/min, the risk picture changes entirely.

In these patients, even modest supplemental doses can accumulate. Symptomatic hypermagnesemia brings nausea, lethargy, muscle weakness, and hypotension. At extreme levels above 1.74 mmol/L, cardiac conduction abnormalities can develop. Severe toxicity typically occurs at doses exceeding 5,000 mg per day, almost always from magnesium-containing laxatives or antacids in patients with compromised renal function. For anyone with CKD considering magnesium, the advice is clear: this is a conversation for a nephrologist, not a health food store aisle.

Drug interactions that matter

Magnesium doesn’t work in isolation. It competes for absorption with a number of commonly prescribed medications, and those interactions are not always top of mind for patients or prescribers.

Uwe Gröber’s comprehensive 2019 review in the International Journal of Molecular Sciences catalogued the interactions that matter most. Proton pump inhibitors (PPIs), taken by millions for acid reflux, reduce magnesium absorption through decreased gastric acidity and can produce hypomagnesemia in roughly 20 percent of long-term users. Thiazide diuretics increase renal magnesium excretion. Certain antibiotics, particularly tetracyclines and fluoroquinolones, form insoluble complexes with magnesium when taken simultaneously, reducing antibiotic absorption by up to 60 to 90 percent.

The practical guidance is straightforward: separate magnesium from these medications by at least two hours. For patients on both a PPI and a thiazide — a common combination in older adults with hypertension and reflux — the net magnesium depletion can be substantial, and supplementation under medical supervision may be warranted.

The exercise study that complicated the narrative

One of the more provocative recent findings comes from a 2025 randomised controlled trial. In healthy young adults who were regular exercisers and free from hypomagnesemia, short-term magnesium supplementation modestly impaired exercise performance — what the authors called “ergolytic” effects — compared to placebo.

“In summary, in healthy young adults who were regular exercisers and free from hypomagnesemia, short-term dietary magnesium supplementation had modest ergolytic effects,” the authors wrote. “We recommend that regular exercisers… should focus on eating high-quality, nutritious foods and refrain from supplementing their diet with magnesium.”

The study is small and its findings don’t generalise to populations with insufficient intake. But it’s a useful caution: magnesium supplementation is not a universal good, and for people already replete, the case for adding more is thin.

What the sleep evidence actually shows

Magnesium’s reputation as a sleep aid is well ahead of its evidence base. A 2025 trial by Julius Schuster and colleagues, published in Nature and Science of Sleep, found that 250 mg of magnesium bisglycinate reduced Insomnia Severity Index scores by roughly 3.9 points compared to 2.3 points for placebo — statistically significant but modest, with a Cohen’s d of approximately 0.2.

More strikingly, a 2026 analysis of the CoLaus cohort in Switzerland, led by researchers at Lausanne University Hospital, found “no consistent association between magnesium supplementation and subjective or objective sleep parameters or restless leg syndrome.” The same analysis reported that people who took magnesium were actually more likely to experience night cramps, not less.

Pedro Marques-Vidal, the senior author, acknowledged this could reflect reverse causation: people who already suffer from cramps may be more likely to seek out magnesium. But the finding is sobering for a supplement marketed as a near-certain remedy for muscle cramps and poor sleep.

The bottom line

Magnesium supplements are safe for the vast majority of people — at recommended doses, in common chelated or salt forms, and in the absence of advanced kidney disease. The adverse effects that do occur are predictable, dose-dependent, and almost entirely gastrointestinal. The open question is whether the NIH’s 350 mg upper limit should be revised upward, and the answer depends on whether you find the CRN’s industry-funded re-evaluation persuasive.

For consumers, the practical takeaways are these: choose magnesium glycinate or bisglycinate if you’re prone to GI sensitivity; stay under 350 mg of elemental magnesium from supplements unless a physician advises otherwise; separate magnesium from antibiotics and thyroid medications by at least two hours; and if your kidneys don’t work well, don’t supplement without medical supervision.

As for sleep and cramp benefits, the evidence is thinner than the marketing suggests, and the 2026 CoLaus data should give pause to anyone treating magnesium as a first-line sleep intervention. As always, consult your doctor before starting any supplement.

References

1. Gröber U. Magnesium and drugs. Int J Mol Sci 20(9):2094. 2019. https://www.mdpi.com/1422-0067/20/9/2094
2. Stadie N, Heinzer R, Marques-Vidal P. Magnesium supplementation, sleep quality, and nocturnal leg cramps: results from the CoLaus|PsyCoLaus cohort study. Eur J Nutr. 2026. https://link.springer.com/article/10.1007/s00394-026-03910-2
3. Schuster J, et al. Magnesium bisglycinate supplementation for sleep: a randomized, double-blind, placebo-controlled trial. Nat Sci Sleep. 2025. https://www.nature.com/articles/s41598-026-50427-z
4. Short-term magnesium supplementation has modest detrimental effects on exercise performance in healthy adults. PMC. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11901567/
5. NIH Office of Dietary Supplements. Magnesium — health professional fact sheet. 2025. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
6. Council for Responsible Nutrition. CRN’s updated evaluation raises safe intake level for magnesium supplements. April 2025. https://crnusa.org/newsroom/crns-updated-evaluation-raises-safe-intake-level-magnesium-supplements